Results For "0"

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform Blog Post

Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—2023年10月5日— Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation software, today announced the…

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model Blog Post

Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023 Sep 1;13(1):1434

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug Blog Post

今日、臨床薬理情報は医薬品添付文書の50％以上を占めています。Inadequate clinical pharmacology development programs can cause sponsors to have significant issues during the review period or impact the…

Certara Launches CoAuthor, a Regulatory and Medical Writing Tool Blog Post

Using AI to gain efficiencies for medical writers PRINCETON, N. J.— 2023年10月3日— Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation software and advanced drug development solutions, today…

Accelerating a drug launch with value communication technology and an integrated workflow Blog Post

With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical company was presented with an opportunity for an accelerated market launch. The team faced several...

Medical Device | Medtronic Demonstrating the economic value of minimally invasive spinal surgery on the iPad Blog Post

このケーススタディでは、iPad上で低侵襲手術の価値を示すために、Webベースのプラットフォームを活用した事例について紹介しています。

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole) Blog Post

Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular, the time-consuming process of updating or modifying tools using custom app vendors would cause significant...

Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma Blog Post

In a sector where both competition and stakeholder expectations are high, a comprehensive approach that blends digital stakeholder engagement with effective value communication is crucial for success. This presentation offers…

Developing Pediatric PBPK Models for Differing Ethnic Populations Blog Post

Physiologically-based pharmacokinetic (PBPK) modeling has proven invaluable in drug development, especially for pediatric populations, because of its ability to reduce and potentially eliminate the need to conduct clinical trials in…

2024 KIC: KoNECT-MOHW-MFDS International Conference​ Blog Post